GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Diamond Biofund Inc (TPE:6901) » Definitions » EV-to-EBITDA

Diamond Biofund (TPE:6901) EV-to-EBITDA : -6.73 (As of May. 19, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Diamond Biofund EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Diamond Biofund's enterprise value is NT$14,313.58 Mil. Diamond Biofund's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-2,126.23 Mil. Therefore, Diamond Biofund's EV-to-EBITDA for today is -6.73.

The historical rank and industry rank for Diamond Biofund's EV-to-EBITDA or its related term are showing as below:

TPE:6901' s EV-to-EBITDA Range Over the Past 10 Years
Min: -6.73   Med: 0   Max: 0
Current: -6.73

TPE:6901's EV-to-EBITDA is ranked worse than
100% of 489 companies
in the Asset Management industry
Industry Median: 9.39 vs TPE:6901: -6.73

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-19), Diamond Biofund's stock price is NT$22.60. Diamond Biofund's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-2.680. Therefore, Diamond Biofund's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Diamond Biofund EV-to-EBITDA Historical Data

The historical data trend for Diamond Biofund's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamond Biofund EV-to-EBITDA Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial - - 42.67 -12.42 -9.66

Diamond Biofund Quarterly Data
Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.67 -15.39 -18.59 -9.66 -8.11

Competitive Comparison of Diamond Biofund's EV-to-EBITDA

For the Asset Management subindustry, Diamond Biofund's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamond Biofund's EV-to-EBITDA Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Diamond Biofund's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Diamond Biofund's EV-to-EBITDA falls into.


;
;

Diamond Biofund EV-to-EBITDA Calculation

Diamond Biofund's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=14313.582/-2126.232
=-6.73

Diamond Biofund's current Enterprise Value is NT$14,313.58 Mil.
Diamond Biofund's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2,126.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diamond Biofund  (TPE:6901) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Diamond Biofund's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=22.60/-2.680
=At Loss

Diamond Biofund's share price for today is NT$22.60.
Diamond Biofund's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2.680.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Diamond Biofund EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Diamond Biofund's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamond Biofund Business Description

Traded in Other Exchanges
N/A
Address
No. 236, Section 4, Xinyi Road,, 11th Floor, Daan District, Taipei City, TWN, 106047
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting global and internationally competitive investment targets, including new drug research and development, high-end medical equipment, innovative medical service technology, medical access, agricultural biotechnology.

Diamond Biofund Headlines

No Headlines